(Press-News.org) Spending time with a medical clown can shorten the length of hospital stay for children with pneumonia, according to research presented at the European Respiratory Society (ERS) Congress in Vienna, Austria [1]. They can also reduce the duration of intravenous antibiotic use.
The study was presented by Dr Karin Yaacoby-Bianu from Carmel Medical Center and the Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
She explains: “Medical clowns undergo specific training to work in hospitals. They have been shown to reduce pain and alleviate stress and anxiety in children and their families during medical treatment, and have been gradually integrated into many aspects of hospital care. But their impact on children being treated for pneumonia has not yet been investigated.
“Community acquired pneumonia is one of the leading causes of hospitalisation in children, globally. A child’s length of hospital stay depends on several factors including their well-being, vital signs, need for intravenous fluids and antibiotics and whether they develop complications.”
The team followed 51 children aged between two and 18 years old, who had been hospitalised due to pneumonia. One group received standard care, the second received standard care plus a 15-minute visit from a medical clown twice daily during the first 48 hours of hospitalisation.
Three medical clowns from The Dream Doctors Project [2] used various techniques to relax the patient, for example music, singing, and guided imagination. They also encouraged the children to drink and eat by themselves again.
The researchers found that the group who were visited by a medical clown had a shorter hospital stay (43.5 hours on average vs 70 hours) and only needed two days of IV antibiotics treatment, compared to three days in the control group. In the clown group, researchers also noted a significant decrease in respiratory rate, heart rate and inflammatory markers.
Dr Yaacoby-Bianu explains: “While the practice of medical clowning is not a standardised interaction, we believe that it helps to alleviate stress and anxiety, improves psychological adjustment to the hospital environment and allows patients to better participate in treatment plans like adherence to oral antibiotics and fluids. This in turn helps the children to recuperate faster.
“Laughter and humour may also have direct physiological benefits by lowering respiratory and heart rates, reducing air trapping, modulating hormones, and enhancing the immune function.”
The team are running further studies on the effect of medical clowns on other diseases to see where they might be most effective.
Dr Stefan Unger is Chair of the ERS Group on Paediatric Respiratory Infection and Immunology and Consultant Respiratory Paediatrician at the Royal Hospital for Children and Young People Edinburgh, UK, and was not involved in the research. He said: “This study indicates the positive effect that humour can have in healthcare settings and emphasises the potential for non-pharmacological interventions to influence clinical outcomes.
“Shortening the length of children’s hospital stays by adding medical clowns to a multidisciplinary care team in cases of pneumonia may reduce physical and emotional stress on children and their families. It may also reduce costs and lift some of the burden on healthcare systems.
“The specific mechanisms by which humour influences clinical outcomes remain a subject for future investigation and further trials in larger patient cohorts are indicated to confirm the findings of this study.”
(ends)
END
Medical clowns shorten hospital stays for children with pneumonia
2024-09-08
ELSE PRESS RELEASES FROM THIS DATE:
New report finds the changing nature of work provides new opportunities for workplace gender equality
2024-09-08
A new research report released today has identified an important shift in how employees choose to engage in the workforce, as they increasingly seek flexibility and opportunities to tailor work schedules and locations to their needs.
The ninth report in the Gender Equity Insights Series from the Bankwest Curtin Economics Centre (BCEC) and the Workplace Gender Equality Agency (WGEA) provides an in-depth analysis of the evolving nature of part-time work and implications of this change for the future of work in Australia.
Despite Australia having one of the highest shares of part-time employment across OECD countries, ...
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
2024-09-08
Insulin resistance is associated with 31 different diseases and, in women, is also linked to higher odds of an early death, a study of data on hundreds of thousands of people in the UK being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.
The conference will hear that there is compelling evidence of links between insulin resistance and conditions as diverse as Parkinson’s diease, gout and sciatica.
Insulin resistance, when the body’s cells don’t respond properly to insulin and can’t easily take up glucose from blood, is a key feature ...
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
2024-09-08
French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new research to be presented at this year’s annual meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
“Glucagon-like peptide-1 agonist (GLP-1) drugs have transformed type 2 diabetes care, but weekly injections can be burdensome for patients. A single shot a month could make it much easier for people living with diabetes or obesity to stick to their drug regimens, improving quality of life and reducing side effects and diabetes complications,” ...
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
2024-09-08
Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) suggests.
The study, from Rhian Hopkins and Ethan de Villiers, of the University of Exeter Medical School, University of Exeter, Exeter, UK, found evidence to suggest that a higher BMI is a cause of severe infections.
In contrast, there was no evidence that mild hyperglycamia contributes ...
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
2024-09-08
Long-term exposure to air pollution and a lack of access to green spaces increases the risk of hospitalisation for respiratory conditions, according to a study presented at the European Respiratory Society (ERS) Congress in Vienna, Austria [1].
Traffic-related air pollution is also strongly linked to the progression from asthma to asthma-COPD, according to a second study also presented at the ERS Congress [2].
Previous research has linked air pollution to an increase in respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), and ...
Better cardiovascular health in early pregnancy may offset high genetic risk
2024-09-07
Research Highlights:
Favorable cardiovascular health in early pregnancy, as measured by the American Heart Association’s Life’s Essential 8 (LE8) cardiovascular health score, was linked to lower risk of preeclampsia and gestational hypertension, otherwise known as hypertensive disorders of pregnancy.
The lower risk among study participants was consistent across different levels of genetic risk for these disorders.
Note: The studies featured in this news release are research abstracts. Abstracts presented at the American Heart Association’s scientific meetings are not peer-reviewed, ...
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
2024-09-07
(San Diego, Calif.--September 7, 2024, 8:30 a.m. PCT) — Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic testing that offers an accurate, cost-effective, and timely method for gene mutation prediction from histopathology slides.
The research was presented today at the IASLC 2024 World Conference on Lung Cancer by Professor Wenhua Liang, from the China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, China.
Accurate ...
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
2024-09-07
(San Diego, Calif.--September 7, 2024, 8:30 a.m. PDT)--The antibody–drug conjugate
ifinatamab deruxtecan (I-DXd) showed clinically meaningful responses in pretreated patients with extensive-stage small cell lung cancer (ES-SCLC), according to an interim analysis of the Phase 2 IDeate-Lung01 study. The data was presented today at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer.
Patients with ES-SCLC face poor outcomes and have limited treatment options. B7 homolog 3 (B7-H3 [CD276]) is part of the B7 family, which includes immune checkpoint proteins such as PD-L1. B7-H3 is highly expressed in many solid tumors ...
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
2024-09-07
[San Diego, Calif --September 7, 2024, 8:30 a.m. PCT)– Despite significant improvements in the perception of biomarker testing compared to a 2018 survey, substantial barriers to implementation persist globally, according to results of the 2024 IASLC Global Survey on Biomarker Testing released today at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2024.
The 2018 survey revealed the adoption of biomarker testing was low due to cost, lack of quality and standards, ...
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
2024-09-07
(San Diego, Calif.---September 7, 2024, 8:30 a.m. PCT) — A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrated a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
In non-small cell lung cancer, immune checkpoint inhibitors offer significant promise, yet their efficacy is limited to a subset of patients. Identifying reliable predictive biomarkers is crucial for optimizing ...